HUM Stock Summary and Trading Ideas (Humana | NYSE:HUM)

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Humana trades on the NYSE stock market under the symbol HUM.

As of April 28, 2026, HUM stock price climbed to $229.72 with 2,765,639 million shares trading.

HUM has a beta of 0.93, meaning it tends to be less sensitive to market movements. HUM has a correlation of 0.07 to the broad based SPY ETF.

HUM has a market cap of $27.70 billion. This is considered a Large Cap stock.

Last quarter Humana reported $33 billion in Revenue and -$3.96 earnings per share. This beat revenue expectation by $640 million and exceeded earnings estimates by $.04.

In the last 3 years, HUM traded as high as $541.21 and as low as $163.11.

The top ETF exchange traded funds that HUM belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.

HUM has underperformed the market in the last year with a return of -11.4%, while SPY returned +30.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in HUM shares. However, HUM has outperformed the market in the last 3 month and 2 week periods, returning +18.9% and +17.1%, while SPY returned +2.6% and +2.5%, respectively. This indicates HUM has been having a stronger performance recently.

HUM support price is $217.04 and resistance is $230.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HUM shares will trade within this expected range on the day.